Related Experiment Video

Updated: May 16, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS

So Young Kim1, Jung Eun Koo, Yun Jee Seo

  • 1School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.

British Journal of Pharmacology
|December 13, 2012
PubMed
Abstract

Insights

Caffeic acid phenethyl ester (CAPE) inhibits Toll-like receptor 4 (TLR4) activation by blocking lipopolysaccharide (LPS) binding to MD2. This novel anti-inflammatory mechanism offers potential for treating chronic inflammatory diseases.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are critical in innate immunity, recognizing pathogens and danger signals to initiate inflammatory responses.
  • Dysregulated TLR activity is linked to immune disorders and chronic inflammatory diseases, highlighting the therapeutic potential of TLR modulators.
  • Phytochemicals are being explored for their ability to modulate TLR activity and mitigate inflammation.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of caffeic acid phenethyl ester (CAPE) on Toll-like receptor 4 (TLR4)-mediated inflammation.
  • To elucidate the underlying molecular mechanism by which CAPE modulates TLR4 activation.

Main Methods:

  • In vivo murine skin inflammation model and in vitro macrophage assays were used to assess CAPE's inhibitory effects on TLR4 activation.
  • Lipopolysaccharide (LPS) binding to MD2 was analyzed using binding assays, immunoprecipitation, and liquid chromatography-tandem mass spectrometry.
  • The specific binding site of CAPE on MD2 was identified, and its functional significance was tested using MD2 mutants.

Main Results:

  • CAPE application reduced dermal inflammation and edema induced by LPS in mice.
  • CAPE suppressed the production of inflammatory mediators and the activation of NF-κB and IRF3 in LPS-stimulated macrophages.
  • CAPE directly inhibited LPS binding to MD2 by forming an adduct with Cys133 in MD2's hydrophobic pocket, which was crucial for its inhibitory effect on IRF3 activation.

Conclusions:

  • CAPE exhibits anti-inflammatory activity by preventing TLR4 activation through a novel mechanism that disrupts the interaction between LPS and the TLR4/MD2 complex.
  • This study provides valuable insights into CAPE's therapeutic potential for preventing and treating chronic inflammatory diseases.

More Related Videos

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...